improving levodopa delivery in pd
Published 3 years ago • 90 plays • Length 4:28Download video MP4
Download video MP3
Similar videos
-
0:51
how can continuous dopaminergic delivery improve outcomes in pd?
-
2:32
latest approaches to improve the delivery of levodopa
-
0:51
emerging levodopa-based treatment strategies for pd: sc delivery
-
2:34
ongoing efforts to improve levodopa-based treatments in parkinson’s disease
-
3:02
subcutaneous 24-hour infusion of foslevodopa/foscarbidopa improves motor symptoms in pd patients
-
2:00
adjunctive mao-b or comt inhibitors to optimize levodopa treatment in pd
-
4:28
opicapone: an adjuvant to levodopa in pd therapy
-
1:06
upcoming advancements in subcutaneous levodopa therapy for pd
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
3:31
nd0612 vs oral immediate-release levodopa/carbidopa in patients with pd and motor fluctuations
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
1:38
carbidopa/levodopa enteral suspension for pd
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
1:20
foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
2:47
design of the epsilon trial of opicapone as an add-on to levodopa in early pd
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
4:19
the impact of lcig on dyskinesia duration & severity in pd